Gaston Matthyssens

Biography

  Dr. Gaston Matthyssens, Ph.D., serves as Managing Partner of Vesalius Biocapital Partners Sarl and Vesalius Biocapital II SA SICAR. Dr. Matthyssens served as an Executive Officer of Ablynx NV. He served as Partner of Value4Growth and worked with Mr. Verdood and Mr. Geldhof since 2001. Dr. Matthyssens joined the management of biotech company Plant Genetic Systems in 1986. In 2001 he co-founded V4G. Dr. Matthyssens served as General Partner of Mara Venture Partners. He served in senior management positions in several biotech companies including Plant Genetic Systems and Corvas Inc. He served as Vice President of Corvas International, Inc., and was responsible for drug discovery and international operations. Since 1997, Dr. Matthyssens served as Business Development Manager and Vice President Business Development of the Flanders Institute for Biotechnology, where he identified mature intellectual property and conceptualized new businesses around it. He served as an Officer of CropDesign N.V. Dr. Matthyssens was responsible for raising venture capital, negotiating valuations and closing the seed round investments for three biotech companies, Devgen NV, CropDesign, and AbLynx. He serves as a Director of Amakem NV, Apitope International NV, Complix NV, Trinean, GenKyoTex S.A. He has been a Member of Supervisory Board of OMEICOS Therapeutics GmbH since April 15, 2015. Dr. Matthyssens served as Director of CareX S.A. He served as a Director of Fovea Pharmaceuticals, SA. He received training in the laboratories of three Nobel Prize winners, Dr. Susumu Tonegawa at the Basel Institute of Immunology and Dr. Cesar Milstein and Fred Sanger at the Medical Research Council Laboratory of Molecular Biology in Cambridge, England. Dr. Matthyssens holds a Ph.D. and a M.Sc. degree in Biochemistry from the Free University of Brussels.

Research Interest

  Biochemistry